XETR
DRW3
Market cap1.85bUSD
Oct 09, Last price
116.60EUR
1D
4.67%
1Q
39.14%
Jan 2017
45.39%
Name
Draegerwerk AG & Co KGaA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Drägerwerk AG & Co. KGaA, a German company established in 1889 and headquartered in Lübeck, operates as a prominent global provider of medical and safety technology. Its business activities extend across Europe, the Americas, Africa, Asia, and Australia. In the medical domain, Dräger specializes in developing, producing, and marketing comprehensive systems, devices, and support services designed for acute point-of-care settings. This encompasses solutions for emergency departments, surgical procedures (perioperative care), intensive care units, and neonatal care. The company's medical portfolio includes anesthesia machines, ventilators, equipment for thermoregulation, various consumables and accessories, medical supply units, lighting, patient monitoring systems, and specialized software applications. For the safety sector, Dräger delivers products, integrated solutions, and services focused on personal protection, sophisticated gas detection technologies, and overall hazard management. Its clientele spans industrial and mining enterprises, as well as public service organizations like fire departments, police forces, and disaster response agencies. Key safety offerings comprise both fixed and portable gas detection systems, personal protective equipment, and devices for alcohol and drug testing. Additionally, Drägerwerk provides extensive training programs and professional services, notably operating specialized fire training facilities for firefighters.
Related entities
Subsidiaries (38)
DRAGER CHILE LIMITADA
Drager Danmark A/S
Drager Holding International GmbH
Drager Interservices GmbH
Drager Medical International GmbH
Drager Medical Mexico S.A. de C.V.
Drager Medical s.r.o.
Drager Safety AG & Co. KGaA
Drager Safety Hungaria Kereskedelmi es Szolgaltato Korlatolt Felelossegu Tarsasag
DRAGER SAFETY ROMANIA SRL
Drager Safety s.r.o.
Drager Schweiz AG
OBSESTVO S OGRANICENNOJ OTVETSTVENNOST'U "DREGER"
PT. Draeger Medical Indonesia
shang hai de er ge yi liao qi xie you xian gong si
shrkt drayjr alrbyt
tai wan de er ge an quan fang hu she bei gu fen you xian gong si
tai wan de er luo yi liao qi cai you xian gong si
Key people
Siegfrid Kasang
Vice Chairman of the Supervisory Board, Employee Representative · since 2005
Reiner Piske
Executive Board Member for Human Resources - Regional Responsibility for Europe, Africa, Asia and Australia · since 2019
Stefan Draeger
Chairman of the Executive Board · since 2018
Uwe Lueders
Independent Member of the Supervisory Board · since 2008
Daniel Friedrich
Member of the Supervisory Board, Employee Representative · since 2006
Thorsten Grenz
Independent Member of the Supervisory Board · since 2008
Stephan Kruse
Member of the Supervisory Board, Employee Representative · since 2018
Klaus Rauscher
Independent Member of the Supervisory Board · since 2008
Bettina van Almsick
Member of the Supervisory Board, Employee Representative · since 2016
Reinhard Zinkann
Independent Member of the Supervisory Board · since 2008
Headquarters & legal address
Moislinger Allee 53-55
Lübeck, SH 23558
DE
Lübeck, SH 23558
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||